International Assets Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Buy
2,074
+122
+6% +$21K 0.02% 577
2026
Q1
$332K Buy
1,952
+19
+1% +$3.25K 0.02% 591
2025
Q4
$326K Sell
1,933
-1,026
-35% -$167K 0.02% 607
2025
Q3
$378K Hold
2,959
0.03% 535
2025
Q2
$374K Sell
2,959
-176
-6% -$21.6K 0.03% 542
2025
Q1
$401K Sell
3,135
-125
-4% -$16.9K 0.04% 476
2024
Q4
$433K Buy
+3,260
New +$458K 0.04% 452
2024
Q3
Sell
-2,929
Closed -$402K 2144
2024
Q2
$402K Buy
2,929
+200
+7% +$26.7K 0.04% 441
2024
Q1
$373K Sell
2,729
-1,412
-34% -$193K 0.04% 452
2023
Q4
$563K Buy
+4,141
New +$505K 0.07% 312
2021
Q2
Sell
-11,039
Closed -$1.67M 1112
2021
Q1
$1.67M Buy
11,039
+5,759
+109% +$915K 0.15% 137
2020
Q4
$800K Sell
5,280
-2,539
-32% -$363K 0.15% 139
2020
Q3
$1.06M Sell
7,819
-4,508
-37% -$612K 0.26% 86
2020
Q2
$1.69M Buy
12,327
+4,949
+67% +$631K 0.4% 50
2020
Q1
$795K Buy
+7,378
New +$849K 0.24% 86

Other funds holding IBB

International Assets Investment Management's IBB Position: Q2 2026 in Review

International Assets Investment Management increased its iShares Biotechnology ETF (IBB) stake by 6.3% in Q2 2026, buying an estimated $21K and bringing the position to 2,074 shares worth $394K. The position accounts for 0.02% of the portfolio, ranked #577.

International Assets Investment Management first reported a position in IBB in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.69M in Q2 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • International Assets Investment Management held 2,074 shares of iShares Biotechnology ETF worth $394K as of Q2 2026.
  • International Assets Investment Management bought 122 iShares Biotechnology ETF shares in Q2 2026, an estimated $21K.
  • iShares Biotechnology ETF made up 0.02% of International Assets Investment Management's portfolio in Q2 2026, its #577 holding.
  • International Assets Investment Management first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 15 quarters since.
  • International Assets Investment Management's iShares Biotechnology ETF position peaked at $1.69M in Q2 2020.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.